Our findings support the hypothesis that PDE4DIP is required for maintaining the full activation of oncogenic RAS/ERK/AKT signaling and thus may play an essential role in KRAS-driven CRC progression. This evidence concerns the gene PDE4DIP and colorectal carcinoma.